Migraine clinical trials

This trial is now closed to new participants

Thank you for your interest in this clinical trial. Recruitment for this study has now finished, and we are no longer accepting new participants.

If you’ve already taken part or registered your interest, our team will continue to support you as usual. If you were hoping to join, we understand this may be disappointing — but don’t worry, we regularly run new trials across a range of health conditions.

Please see our current available trials below.

About migraine research

Migraine affects around one in seven people and is among the leading causes of years lived with disability worldwide. It is considerably more common in women than men, and for many people attacks follow patterns linked to hormonal changes.

Why migraine research matters

Migraine is frequently underestimated. It is a neurological condition rather than a severe headache, and for many people attacks involve visual disturbance, nausea and sensitivity to light and sound alongside pain, with a recovery period afterwards.

Menstrual migraine, where attacks cluster around the menstrual cycle, has historically received less research attention than migraine generally, despite affecting a substantial number of women. That imbalance is part of a wider under-representation of women’s health in clinical research, which is beginning to be addressed.

What taking part usually involves

Migraine studies typically ask participants to keep a diary recording when attacks occur, how long they last and what accompanies them. This is central to the research rather than incidental, since the pattern is often what is being studied.

Studies may run across several cycles to capture enough attacks to be meaningful. Visits are usually spaced accordingly, and the study team explains the recording process fully at the start. Taking part is voluntary and you may withdraw at any point.